Public Opinion

Total Page:16

File Type:pdf, Size:1020Kb

Public Opinion Vo lume 44 Number 1 JANUARY 2020 Volume 44 Number 1 Advancing Development & Manufacturing PharmTech.com Navigating Rocky PH ARMACEUTICAL TECHNOLOGY Public Opinion Special Coverage Annual Employment Survey Human Element in Pharma Development 2019 Drug Approvals Formulating Biologics Manufacturing Predictive Maintenance Wet Granulation PAT Quality/Regulations Getting to the Root Cause VHP Decontamination Myths JANUARY 2020 JANUARY Operations Sustainable Packaging Peer-Review Research Oral Reconstitutable PharmTech.com Suspension Analysis the next highly potent compound... Let’s develop it together. Specialty expertise in highly potent APIs We also offer particle engineering Visit pharma.lonza.com (particle size reduction and spray drying) Email [email protected] Identifying a collaboration partner that under isolation as well as specialized dosage © 2020 Lonza. All rights reserved. can meet the aggressive timelines often forms designed for highly potent, low dose associated with highly potent drug candidates applications. We have more than 20 years’ is critical. At Lonza Pharma & Biotech, we track record in HPAPI manufacturing and offer the necessary development, upscaling compressed scale-up timelines. and manufacturing capabilities under full containment that support API handling to A partner that you can count on for all exposure levels to 1ng/m3. aspects of your drug program – Lonza. LPB HPAPI 1219 – Pharmaceutical Technology US HPAPI_Ad_PharmTech_US_final.indd 1 12/17/19 11:33 AM BIG Pharma? BIG Mixers. Ross supplies the largest Double Planetary Mixers in the Pharmaceutical Industry. Sanitary design, IQ/OQ documentation, SIP capability. Perfect for mixing and homogenous granulations. Custom PLC recipe controls are available to optimize your batch data and meet CFR-21 requirements. With units sized from 200mL to 4000L, Ross has the Double Planetary Mixer to fit your process. Learn more at mixers.com. Call 1-800-243-ROSS or try ourr free online Knowledge Base & Product Selector web app at mixers.com/web-app. 4000L 200mL Scan to learn more. magentablackcyanyellow 36017110788_6559280.pgs 10.12.2017 00:19 ADVANSTAR_PDF/X-1a EDITORIAL SALES Editorial Director Rita Peters [email protected] Publisher Mike Tracey [email protected] Senior Editor Agnes Shanley [email protected] East Coast Sales Manager Joel Kern [email protected] Managing Editor Susan Haigney [email protected] Mid West, West Coast Sales Manager BJ Ghiglione [email protected] European Editor Felicity Thomas [email protected] European Sales Manager Linda Hewitt [email protected] Manufacturing Editor Jennifer Markarian [email protected] European Senior Sales Executive Stephen Cleland [email protected] Science Editor Feliza Mirasol [email protected] Executive Assistant Barbara Sefchick [email protected] Assistant Editor Lauren Lavelle [email protected] C.A.S.T. Data and List Information Michael Kushner [email protected] Senior Art Director Marie Maresco; Graphic Designer Maria Reyes VP/Managing Director, Pharm/Science Group Dave Esola Contributing Editors Jill Wechsler [email protected]; Hallie Forcinio [email protected]; ADDRESS Susan J. Schniepp [email protected]; Eric Langer [email protected]; 485 Route One South, Building F, Second Floor, Iselin, NJ 08830, USA and Cynthia A. Challener, PhD [email protected] Tel. 732.596.0276, Fax 732.647.1235 Correspondent Sean Milmo (Europe, [email protected]) PharmTech.com 485 Route One South, Building F, Second Floor, Iselin, NJ 08830, USA Tel. 732.596.0276, Fax 732.647.1235, PharmTech.com Permissions Alexa Rockenstein, [email protected] EDITORIAL ADVISORY BOARD Audience Development Research Director Pharmaceutical Technology publishes contributed technical articles that undergo a Christine Shappell [email protected] rigorous, double-blind peer-review process involving members of our distinguished Editorial Advisory Board. Manuscripts should be sent directly to the managing editor. Below is a partial list of the TM Pharmaceutical Technology brand editorial advisory members. The full board, which includes advisory members MJH LIFE SCIENCES from Pharmaceutical Technology Europe, can be found online at PharmTech.com. Chairman and Founder Mike Hennessy, Sr Vice Chairman Jack Lepping James P. Agalloco Sanjay Garg, PhD Moheb M. Nasr, PhD President and CEO Mike Hennessy, Jr President Professor and Director, Principal Agalloco & Associates Centre for Pharmaceutical Nasr Pharma Regulatory Consulting Chief Financial Officer Neil Glasser, CPA/CFE Innovation and Development, Larry L. Augsburger, PhD University of South Australia Garnet E. Peck, PhD Executive Vice President, Operations Tom Tolvé Professor Emeritus Professor Emeritus of Industrial University of Maryland R. Gary Hollenbeck, PhD Pharmacy, Purdue University Senior Vice President, Content Silas Inman Research Faculty Senior Vice President, I.T. & Enterprise Systems John Moricone David H. Bergstrom, PhD University of Maryland Wendy Saffell-Clemmer Senior Vice-President, School of Pharmacy Director, Research Senior Vice President, Audience Generation & Product Fulfillment Joy Puzzo Pharmaceutical Development & Baxter Healthcare Corporate Quality Assurance Ruey-ching (Richard) Hwang, PhD Vice President, Human Resources & Administration Shari Lundenberg Antares Pharma, Inc. Senior Director, Gurvinder Singh Rekhi, PhD Pharmaceutical Sciences, Department of Pharmaceutical and Vice President, Business Intelligence Chris Hennessy Phil Borman, DSc Pfizer Global R&D Biomedical Sciences, Director The University of Georgia College Vice President, Corporate Branding & B2B Marketing Amy Erdman Product Development & Supply Maik W. Jornitz of Pharmacy Executive Creative Director, Creative Services Jeff Brown Medicinal Science & Technology President Susan. J. Schniepp Pharma R&D G-CON Manufacturing Inc. GlaxoSmithKline Executive Vice-President of Mansoor A. Khan, PhD Post-approval Pharmaceuticals and Evonne Brennan Professor & Vice Dean Distinguished Fellow International Technical Marketing Irma Lerma Rangel College of Regulatory Compliance Associates Manager, Pharmaceutical Division, Pharmacy, Texas A&M Health David R. Schoneker IMCD Ireland Science Center Director of Global Regulatory Affairs, Rory Budihandojo Russell E. Madsen Colorcon Lachman Consultants President, Aloka Srinivasan The Williamsburg Group, LLC Metin Çelik, PhD VP, Regulatory President, Heidi M. Mansour, PhD Lachman Consultants Pharmaceutical Technologies Assistant Professor Read board members’ International (PTI) College of Pharmacy biographies online at & The BIO5 Research Institute, PharmTech.com/ © 2020 MultiMedia Pharma Sciences LLC All rights reserved. No part of this publication may be reproduced or Zak T. Chowhan, PhD University of Arizona–Tucson transmitted in any form or by any means, electronic or mechanical including by photocopy, recording, or information Consultant, Pharmaceutical pharmtech-editorial- Development Jim Miller advisory-board. storage and retrieval without permission in writing from the publisher. Authorization to photocopy items for internal/ Founder and Former President, educational or personal use, or the internal/educational or personal use of specific clients is granted by MultiMedia Suggy S. Chrai, PhD PharmSource, A Global Data Pharma Sciences LLC for libraries and other users registered with the Copyright Clearance Center, 222 Rosewood Dr. President and CEO, Company Chrai Associates, Inc. Danvers, MA 01923, 978-750-8400 fax 978-646-8700 or visit http://www.copyright.com online. For uses beyond those Colin Minchom, PhD listed above, please direct your written request to Permission Dept. or email: [email protected] Roger Dabbah, PhD Senior Director Pharmaceutical Principal Consultant, Sciences, Shire Pharmaceuticals MultiMedia Pharma Sciences LLC provides certain customer contact data (such as customers name, addresses, Tri-Intersect Solutions phone numbers, and e-mail addresses) to third parties who wish to promote relevant products, services, and other R. Christian Moreton, PhD Robert Dream Partner, Finnbrit Consulting opportunities that may be of interest to you. If you do not want MultiMedia Pharma Sciences LLC to make your contact Managing Director information available to third parties for marketing purposes, simply email [email protected] and a customer HDR Company Fernando J. Muzzio, PhD service representative will assist you in removing your name from MultiMedia Pharma Sciences LLC lists. Director, NSF Engineering Tim Freeman Research Center on Structured Managing Director, Pharmaceutical Technology does not verify any claims or other information appearing in any of the advertisements con- Organic Particulate Systems, tained in the publication, and cannot take responsibility for any losses or other damages incurred by readers in reliance FreemanTechnology Dept. of Chemical and Biochemical Engineering, Rutgers University of such content. Pharmaceutical Technology welcomes unsolicited articles, manuscripts, photographs, illustrations, and other materials but cannot be held responsible for their safekeeping or return. Reprints: Contact Mike Tracey, [email protected]. Display, Web, Classified, and Recruitment Advertising: Contact, tel. 732.346.3027. Permissions: Contact Alexa Rockenstein, tel. 732.346.3007, [email protected]. Pharmaceutical Technology’s eNewsletter Team: To subscribe: [email protected] • ePT, Editor Lauren Lavelle, [email protected] • In the Lab,
Recommended publications
  • HCL Software's
    IBM Branded, Fujistu Branded and Panasonic Branded Products and Related Services and Cloud Services Contract DIR-TSO-3999 PRICING SHEET PRODUCTS AND RELATED SERVICES PRICING SHEET RESPONDING VENDOR COMPANY NAME:____Sirius Computer Solutions_______________ PROPOSED BRAND:__HCL Software__________________________ BRANDED PRODUCTS AND RELATED SERVICES Software * This file is generated for use within the United States. All prices shown are US Dollars. * Products & prices are effective as of the date of this file and are subject to change at any time. * HCL may announce new or withdraw products from marketing after the effective date of this file. * Nothwithstanding the product list and prices identified on this file, customer proposals/quotations issued will reflect HCL's current offerings and commercial list prices. * Product list is not all inclusive and may not include products removed from availability (sale) or added after the date of this update. * Product availability is not guaranteed. Not all products listed below are found on every State/Local government contract. DIR DIR CUSTOMER Customer Product Category PRICE (MSRP- Discount % Description or SubCategory Product Description and/or Service Description Part Number MSRP DIR CUSTOMER off MSRP* of MSRP or Services* DISCOUNT Plus (2 Admin Fee) Decimals) HCL SLED Third Party CNTENT/COLLAB ACC AND WEBSPH PRTL SVR INTRANET PVU ANNUAL SW S&S RNWL E045KLL $786.02 14.50% $677.09 Price HCL SLED Third Party HCL APP SEC OPEN SOURCE ANALYZER CONSCAN PER CONCURRENT EVENT PER ANNUM D20H6LL $41,118.32
    [Show full text]
  • Approved for Public Release LPF Environmental Assessment
    DOE/EA-2145 ENVIRONMENTAL ASSESSMENT FOR THE LITHIUM PROCESSING FACILITY AT THE Y-12 NATIONAL SECURITY COMPLEX, OAK RIDGE, TENNESSEE Final March 2021 Approved for Public Release LPF Environmental Assessment EXECUTIVE SUMMARY The National Nuclear Security Administration (NNSA), a semi-autonomous agency within the United States (U.S.) Department of Energy (DOE), has the primary responsibility to maintain and enhance the safety, security, and effectiveness of the U.S. nuclear weapons stockpile. One of NNSA’s critical production sites is the Y-12 National Security Complex (Y-12), which is located on the Oak Ridge Reservation (ORR) in Oak Ridge, Tennessee. Y-12 is the only source of secondaries, cases, lithium components, and other nuclear weapon components for the NNSA nuclear security mission. Lithium, which is the subject of this environmental assessment (EA), is an essential element for the refurbishment and modernization of the nuclear weapons stockpile. NNSA has prepared this EA to analyze the potential environmental impacts associated with constructing and operating the Lithium Processing Facility (LPF) to process and supply the lithium material and components that are needed to support the National Security Enterprise. Currently, processing work for enriched lithium vital to weapon components is primarily performed in Building 9204-2, which was built in 1943. The facility, at approximately 325,000 square feet, is oversized for today’s mission, was not built in accordance with current codes and standards, is costly to operate, has many operating issues, and has exceeded its expected life. Replacing Building 9204-2 with a new LPF that is code compliant would improve employee safety; reduce the site’s footprint; improve facility operations to provide energy-efficient assets; and reduce operation and maintenance costs.
    [Show full text]
  • Chromogenic and Fluorogenic Probes for the Detection of Illicit Drugs
    DOI:10.1002/open.201800034 Chromogenic and Fluorogenic Probes for the Detection of Illicit Drugs Eva Garrido+,[a] Luis Pla+,[a] Beatriz Lozano-Torres,[a] Sameh El Sayed,[a, b] RamónMartínez-MµÇez,*[a, b, c] and FØlix Sancenón[a, b, c] ChemistryOpen 2018, 7,401 –428 401 2018 The Authors. PublishedbyWiley-VCH Verlag GmbH &Co. KGaA, Weinheim The consumption of illicit drugs has increased exponentially in sary to develop highly rapid, easy,sensitive,and selective recent years and has become aproblem that worries both methods for their detection. Currently,the most widely used governments and international institutions. The rapid emer- methods for drug detection are based on techniques that re- gence of new compounds, their easy access,the low levels at quire large measurement times, the use of sophisticated equip- which these substances are able to produce an effect, and ment, and qualified personnel. Chromo-and fluorogenic meth- their short time of permanence in the organism makeitneces- ods are an alternative to those classical procedures. 1. Introduction euro), ecstasy(22 million euro), opiates (18 millioneuro), and cocaine(17 million euro). According to their pharmacologic be- The use of novel illicit drugs and the constant appearance of havior,drugs can be divided into depressants, stimulants, hal- new psychoactive substances have rapidlygrown in the last lucinogenic, and opioids. years, and reports of the availability and manufacture of such Because of their harmfulnesstohealth,the ability to detect substances have increased.[1] Illicit drugs are those for which and quantify “drugsofabuse” in afast, easy,and reliable way nonmedicaluse has been prohibited by internationalcontrol is crucial.
    [Show full text]
  • HCL Sametime
    HCL Sametine Mensajería instantánea y reuniones online para tu entorno laboral HCL Sametime La mensajería instantánea HCL Sametime facilita la comunicación en tu entorno de negocio. Ofrece una experiencia de usuario unificada para la mensajería instantánea, las reuniones online, los mensajes de voz, de vídeo, los datos y más. Accede a reuniones online desde el escritorio, el portátil, la tablet o el móvil. Comparte archivos, aplicaciones y pantallas de forma interna o externa utilizando funciones seguras. La conexión en un clic con compañeros permite acceder rápidamente a información y cumplir con las necesidades diarias del negocio. HCL Sametime trae la comunicación social a los procesos de empresa con una experiencia de usuario y una integración unificadas. Comunícate como quieras y al instante. HCL Sametime es un conjunto de productos de comunicación para empresa en tiempo real que proporciona funciones completas de colaboración privada o en grupo, incluyendo mensajería instantánea (IM, en inglés), voz, vídeo, conferencias y telefonía. Piensa en HCL Sametime como el Último paso en la plataforma de comunicación social de una empresa. Piensa en un empleado de primera línea del centro de asistencia que necesita contar rápidamente con un experto o una persona que tome una decisión. Con HCL Encuentra el Sametime, ese empleado puede ver fácilmente quién está disponible para ayudarle conocimiento echando un vistazo al directorio de empresa o al programa de email. En solo unos clics, la persona adecuada podrá conectarse por IM, teléfono o videollamada. Así, la respuesta al cliente es más rápida y la satisfacción del cliente será mayor. La reducción del presupuesto para viajes quiere decir que no siempre es posible HCL Saparam el peersontal rieumnirse een persona con los clientes para recoger sus valoraciones.
    [Show full text]
  • Polcawich, Ronald: Design, Fabrication, Test, and Evaluation Of
    The Pennsylvania State University The Graduate School Department of Materials Science and Engineering DESIGN, FABRICATION, TEST, AND EVALUATION OF RF MEMS SERIES SWITCHES USING LEAD ZIRCONATE TITANATE (PZT) THIN FILM ACTUATORS A Thesis in Materials Science and Engineering by Ronald G. Polcawich ©2007 Ronald G. Polcawich Submitted in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy August 2007 The thesis of Ronald G. Polcawich was reviewed and approved* by the following: Susan Trolier-McKinstry Professor of Ceramic Science and Engineering Thesis Advisor Chair of Committee Clive A. Randall Professor of Materials Science and Engineering Thomas R. Shrout Professor of Materials Srinivas Tadigadapa Associate Professor of Electrical Engineering Madan Dubey Research Physicist, US Army Research Laboratory Special Member Gary Messing Distinguished Professor of Ceramic Science and Engineering Head of Department of Materials Science and Engineering *Signatures are on file in the Graduate School. Abstract The aim of this thesis was to design and prototype a robust, low voltage RF MEMS switch for use in military phased arrays. The frequencies of interest for this work include very low frequencies down to DC operation with the upper limit extending to at least 40 GHz. This broad frequency requirement requires a robust high frequency design and simulation using microwave transmission lines. With the aid of researchers at the US Army Research Laboratory, co-planar waveguide (CPW) transmission lines were chosen and designed to provide a low loss, 50 ohm impedance transmission line for the switch. CPW designs allow for both series and shunt switch configuration with this work focusing on a series switch.
    [Show full text]
  • For Product Developers and Solution Providers in the Zigbee Sector
    Smart Building B2B For Product Developers and Solution Providers in the Zigbee Sector Smart Building B2B For Product Developers and Solution Providers in the Zigbee Sector 2020/21 Content Content Introduction 8 Zigbee luminaire module 56 Solutions 10 Zigbee development board 57 Interface 12 Zigbee Gateway solutions and services 59 Energy efficiency 14 Software libraries 62 Alarm and security functions 16 Network Manager 66 Scheduled actions 20 Smart Building Products (also as OEM) 68 Scenes 22 Gateway G1 71 Configuration 24 Interface 74 Amazon Echo 26 Lighting and consumers 75 Apple HomeKit 28 Shading 78 Energy-independent push button 30 Climate 79 Human Centric Lighting (HCL) 32 Additional options 84 Data visualization 34 Zigbee USB stick U1 85 Mini-app store 36 Reference examples 88 JavaScript engine 38 Compatibility 90 System overview 40 Installation 94 Products for Zigbee product developers 42 Technology and innovation 98 Zigbee Stack Solutions 44 Quality claim and data protection 102 Zigbee USB stick U1 53 Contact 106 IEEE 802.15.4 Wireshark USB stick 54 Imprint 108 6 7 Introduction Introduction As one of the world‘s leading companies in the ubisys also offers the current product range in Internet of Things (IoT) industry, based in the form of customer-specific custom-made Düsseldorf, ubisys develops smart products products or white label solutions. and solutions for networked building techno- We attach particular importance to promote the logy and helps other manufacturers to prepare development of the major international wireless their products for the digital age. networking standards, which we significantly Whether you are a luminaire manufacturer, real influence in major positions within the Zigbee estate developer or chip manufacturer, ubisys Alliance.
    [Show full text]
  • Commercial Driver's License (CDL Manual)
    2019 CDL Manual Changes Attention Commercial Drivers Commercial Driver’s License Drug and Alcohol Clearinghouse The Clearinghouse is a secure online database that will provide FMCSA and employers the ability to identify real-time drivers who are prohibited from operating a CMV based on DOT drug and alcohol program violations and ensure that such drivers receive the required evaluation and treatment before operating a CMV on public roads. Specifically, information maintained in the Clearinghouse will enable employers to identify drivers who commit a drug or alcohol program violation while working for one employer, but who fail to subsequently inform another employer as required by current regulations. Records of drug and alcohol program violations will remain in the Clearinghouse for five years, or until the driver has completed the return-to-duty process, whichever is later. The Clearinghouse will contain only violations that occurred on or after the rule’s implementation date of January 4, 2020. Read the Clearinghouse final rule at: www.fmcsa.dot.gov/regulations/commercial-drivers- license-drug-and-alcohol-clearinghouse Large Vehicles Must Yield in Roundabouts (M.S. 169.20) In multiple lane roundabouts, if two vehicles with a total length in excess of 40 feet, a total width of 10 feet, or any combination of vehicles, approach and drive through at approximately the same time, the vehicle on the right must yield the right of way to the vehicle on the left and, if necessary, reduce speed or stop. Table of Contents Part A Minnesota Commercial Driver’s License Requirements .............................................................................. 1 Class of Licenses ........................................................................................................................ 1 Endorsements and Restrictions ..................................................................................................
    [Show full text]
  • 2020 04 Tele.Pdf
    WWW.REPORT.AT DAS MAGAZIN FÜR WISSEN, TECHNIK UND VORSPRUNG Ausgabe 04 | 2020 INSIDE Risikofaktor Ist die IT kompromittiert, sind Unternehmen in Gefahr. Wie man sich schützen kann. 20. Jahrgang, P. b. b. Verlagspostamt 1170 Wien, Vertriebskennzahl 02 Z030627M, Preis: EUR 4,– Preis: 02 Z030627M, Vertriebskennzahl Wien, 1170 Verlagspostamt b. b. P. Jahrgang, 20. 16 24 34 #reporttalk Auszeichnung Aus der Krise Das Gespräch zu Informations- »eAward: Lösungen für neues Organisationen in die Zukunft sicherheit und Resilienz Wirtschaften« – alle Sieger führen – Teil 1 INHALT > das magazin für wissen, technik und vorsprung MARTIN SZELGRAD Chefredakteur EuGH findet klare Worte m Juli hat der Europäische Gerichtshof klargestellt, dass FRAUEN IN DER IT RESILIENZ STÄRKEN I die weitreichenden Über- 10 Auftaktveranstaltung der Initiative 16 Was Backup und Restore mit #WOMENinICT IT-Sicherheit zu tun haben wachungsgesetze in den USA im Widerspruch zu den Grundrechten der EU stehen. Warum? Die USA beschrän- ken die meisten Schutzmaßnahmen auf US-Personen, schützen aber nicht die Daten europäischer Kunden von US-Dienstleistern respektive generell 3 Firmen mit einer Niederlassung in den USA vor Überwachung Das internationale Cloud-Business wird deswegen nicht zusammen- 24 38 brechen, denn weiterhin können eAward Best of ... KI in der Praxis »notwendige« Datenübermittlungen Lösungen für neues Wirtschaften – Optimierungen in der Logistik und gemäß Artikel 49 DSGVO stattfinden beste Produkte und Services bei Getränkeherstellern – ebenso Datenübermittlungen, die notwendig sind, um einen Vertrag zu erfüllen. Wollen Nutzer ihre Daten ins Ausland fließen lassen, ist dies nach 04 Inside. Neues aus der heimischen 32 Workplace. ALE-Geschäftsführer wie vor legal möglich – dies müsse IKT-Landschaft Christian Doleschal im Gespräch aber auf eine »informierte Einwilli- Köpfe.
    [Show full text]
  • Why Capture IM & Collaboration Content?
    IM & COLLABORATION Remove restrictions on your employees’ use of the latest, most hyper productive IM & collaboration tools Why capture IM & collaboration content? IM & collaboration tools are overtaking email as employees’ chosen method of conducting business. As part of a highly regulated and litigious industry, you are required to retain and supervise these communications. Additionally, your business needs to be able to search and access emails for e-discovery and internal investigations. Retaining IM & collaboration messages centrally alongside all your other communications both exposes conversational context and enables the application of uniform compliance processes. It results in a significantly more efficient review process, lower costs to your organization and better outcomes. Key features Direct capture Message threading Profile and identity and native format management Attachment support Automatic indexing Smarsh Connected Archive and external archive support US: +1 (866) 762–7741 UK: +44 (0) 800-048-8612 www.smarsh.com IM & COLLABORATION Secure peace of mind with compliant capture of all your IM & collaboration communications How it works Smarsh has developed close relationships with the leading IM & collaboration platforms. What this means for our customers is compliant Supported channels include: access to all the latest channels such as Microsoft Teams, Slack and Webex Teams and others. The capture and archiving of all this data can be enabled for either individuals or across your entire organization directly - without relying on third parties. Once captured, all content is automatically sent Microsoft Teams Salesforce Chatter encrypted to the Smarsh Connected Archive where it is available for fast, on-demand search alongside all other archived communications.
    [Show full text]
  • Digital Delivery Toolkit
    Digital Delivery Toolkit Version 1: September 2020 Digital Delivery Toolkit September 2020 Digital Delivery Toolkit Contents 1. Introduction ………………………………………….Page 2 2. Digital Approaches and Considerations…………..Page 3-7 3. Inclusion and Accessibility………………………….Page 8-13 4. Safeguarding…………………………………………Page 14-16 5. Copyright and Permissions…………………………Page 17-18 6. Data Collection and Evaluation…………………….Page 19-20 7. Tips for Engagement and Interactivity…………….Page 21-22 Appendix 1: Activity Planning Template……………..Page 23-24 Appendix 2: Examples of Online Platforms………….Page 25-26 1. Introduction This Toolkit is aimed at Widening Participation outreach practitioners, teachers and anyone else who has had to adapt from delivering activities and events face-to-face, to online. The content has been curated and created by Future Quest staff. For more information about who we are and what we do, please visit our website: FutureQuest.org.uk. We hope you will find this Toolkit helpful as you plan your digital activities and events. If you have any comments about this Toolkit please contact us at [email protected]. Page 2 of 26 Digital Delivery Toolkit September 2020 2. Digital Approaches and Considerations STEP 1: Decide on your approach There are three different approaches you can take to develop digital delivery: 1. Curate content 2. Adapt existing face-to-face content 3. Create new content Think about the activity you want to deliver in a digital format… Does the activity already exist in a digital format elsewhere? Yes No Take the Do you already have approach: content? Curate Content No Could the activity still Yes meet the learning Take the objective(s) in a digital approach: format and the success Create New be measured? Content Yes No Do you have the time and resources to adapt the activity? Yes No Consider alternative activity for your Take the learning objective(s) approach: Adapt Existing Content Page 3 of 26 Digital Delivery Toolkit September 2020 1.
    [Show full text]
  • HCL Sametime 11
    HCL HCL Sametime 11 Installation and Administration Guide Rebecca Nethala 12-16-2019 Contents System Requirements ................................................................................................................................... 2 Installation (Servers) ..................................................................................................................................... 2 Sametime Community V11 Server Install ..................................................................................................... 2 Install Domino V11 ........................................................................................................................................ 2 Set up Domino .............................................................................................................................................. 4 Steps to Set up Domino ............................................................................................................................ 4 Install MongoDB ............................................................................................................................................ 5 Configure MongoDB...................................................................................................................................... 6 Install the Sametime Community Server .................................................................................................... 13 Before you begin ....................................................................................................................................
    [Show full text]
  • Westfield Studios and Blanks Were Left in the Docu- Nnnutil Messajre from the Prcsiileht to Cuntfn'us
    THE WESTFIELD LEADER THE LEADING AND MOST WIDELY CIRCULATED WEEKLY NEWSPAPER IN UNION COUNTY Y-THIRD YEAR—No. 14 at Westfleld, X. J. WESTFIELD, NEW JERSEY, THURSDAY, NOVEMBER 29, 1902 rond clasa Postage Paid Kvt-ry Tliurmlay 38 Page*—10 Cent* Bike Inspection Tragedy Narroivly Averted [elch Motion To Defer The monthly bicycle inspec- tion will be held Saturday from 9 a.m. to 11:30 a.m. at evaluation Plan For the rear of Police Headquar- ters in the Municipal Build* ing, police Lt. Thomas Cata- Four Firemen Burned Battling Lacks Support lon announced today* lA lone official move to defer Wcstfii-ld's application of new prop- fc-ssessments until lillM failed to pain a second ut Tuesday nijtfit's Poliee Chief Urges School Bus Fire At Holy Trinity lil session and died. Third Ward Councilman IlerlK-it R. Welch toiHtscd Uu? delay aflor council returnwl from a IS minuu-s recess pjr the purpose of discussing tho revaluation o,uustion, target of Extra Care For preud complaints. 'Condition Good' Deputy Chief Baker, R. McMiuius fmcilmun Welch offered a mo- defer u«« of the now fi£- Saturday Hearing Winter Travel At n lute hour yesterday Overlook Hospital, Summit, reported that the condition'.-! of Deputy Chief Samuel Haker Hospitalized; 3 Girls Escape Ibwause of the ' "widespread Edward V. Ehler»t adminii- and nikundiTstundiiiK*" Police Chief James K. Moran tt>- and Kireinen Hubert iMdManus were "K'OOII." The pair suffered I^onr Wf^Rlfiold firemen wore hurned, two serioualy, Tuesday trative atkiitant to Mayor Burr dny ur^ed mot-ori-sUs to prepare tinted out that under the law nfternoon when they utU'inptwl to enter n tlainhiK st-hool 1ms ut Holy A.
    [Show full text]